Digibug. Repositorio Institucional de la Universidad de Granada
Publication
Artículo científico (JournalArticle)
N-Aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: design, synthesis, computational studies, and antitumor effect
Supplementary data to this article can be found online at https://doi.org/10.1016/j.ejmech.2023.115570., Funding
This research was funded by the Consejería de Universidad, Inves-
tigaci´on e Innovaci´on of the Junta de Andalucía and FEDER, Una
manera de hacer Europa (P18-RT-1679, PT18-TP-4160, B-FQM-475-
UGR18 and PAIDI-TC-PVT-PSETC-2.0.), the Research Results Transfer
Office (OTRI) of the University of Granada (PR/17/006), the Spanish
Ministry of Economy and Competitiveness (PID2019.110987RB.I00 and
PID2021.128109OB.I00) and the Health Institute Carlos III (DTS18/
00121). C.D. thanks HECBioSim, the UK High End Computing Con-
sortium for Biomolecular Simulation (hecbiosim.ac.uk), which is sup-
ported by the EPSRC (EP/L000253/1) for awarding computing time in
Jade, a UK Tier-2 resource. B.R.-R. gratefully acknowledges funding
from the European Union’s Horizon 2020 Research and Innovation
Program under Marie Sklodowska-Curie Grant Agreement no. 754446
and UGR Research and Knowledge Transfer Fund—Athenea3i. J.M.E.-R.
thanks the Spanish Ministry of Education for a studentship (FPU 16/
02061). A.M.-M. gratefully acknowledges funding from the HPC-
Europa3 Transnational Access programme supported by the European
Commission H2020 Research & Innovation GA # 730897 (application
number HPC17ARM6V). Funding for open access charge: Universidad
de Granada / CBUA., Hyaluronic acid (HA) plays a crucial role in tumor growth and invasion through its interaction with cluster of differentiation 44 (CD44), a non-kinase transmembrane glycoprotein, among other hyaladherins. CD44 expression is elevated in many solid tumors, and its interaction with HA is associated with cancer and angiogenesis. Despite efforts to inhibit HA-CD44 interaction, there has been limited progress in the development of small molecule inhibitors. As a contribution to this endeavour, we designed and synthesized a series of N-aryltetrahydroisoquinoline derivatives based on existing crystallographic data available for CD44 and HA. Hit 2e was identified within these structures for its antiproliferative effect against two CD44+ cancer cell lines, and two new analogs (5 and 6) were then synthesized and evaluated as CD44-HA inhibitors by applying computational and cell-based CD44 binding studies. Compound 2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-5-ol (5) has an EC50 value of 0.59 μM against MDA-MB-231 cells and is effective to disrupt the integrity of cancer spheroids and reduce the viability of MDA-MB-231 cells in a dose-dependent manner. These results suggest lead 5 as a promising candidate for further investigation in cancer treatment., Consejería de Universidad, Investigación e Innovación of the Junta de Andalucía and FEDER, Una
manera de hacer Europa (P18-RT-1679, PT18-TP-4160, B-FQM-475-
UGR18 and PAIDI-TC-PVT-PSETC-2.0.), Research Results Transfer
Office (OTRI) of the University of Granada (PR/17/006),, panish
Ministry of Economy and Competitiveness (PID2019.110987RB.I00 and
PID2021.128109OB.I0), Health Institute Carlos III (DTS18/
00121), EPSRC (EP/L000253/1), European Union’s Horizon 2020 Research and Innovation
Program under Marie Sklodowska-Curie Grant Agreement no. 754446, HPC-Europa3 Transnational Access programme supported by the European
Commission H2020 Research & Innovation GA # 730897, Funding for open access charge: Universidad de Granada / CBUA.